Wexford Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-110,882	Closed	-$2.25M	–	127
2019 Q2	$2.25M	Hold	110,882	–	–	0.26%	63
2019 Q1	$1.95M	Hold	110,882	–	–	0.16%	54
2018 Q4	$1.42M	Buy	110,882 +79,082	+249%	+$1.01M	0.12%	45
2018 Q3	$518K	Buy	+31,800	New	+$518K	0.03%	119